Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 1/20 | 0.59 |
| ▸ | PPARA | Q07869 | 1/20 | 0.59 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.57 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.56 |
| ▸ | ALPI | P09923 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | XIAP | P98170 | 1/20 | 0.56 |
| ▸ | MME | P08473 | 1/20 | 0.54 |
| ▸ | TPH1 | P17752 | 3/20 | 0.51 |
| ▸ | SRR | Q9GZT4 | 2/20 | 0.50 |
| ▸ | PSAT1 | Q9Y617 | 2/20 | 0.50 |
| ▸ | TPH2 | Q8IWU9 | 1/20 | 0.49 |
| ▸ | NOS3 | P29474 | 1/20 | 0.49 |
| ▸ | NOS1 | P29475 | 1/20 | 0.49 |
| ▸ | NOS2 | P35228 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31369541 | 0.90 | GRIA2 (0.71) | PPARGPPARAGRIA2SLC7A5ALPI | |
| SCHEMBL180285 | 0.88 | SLC7A5 (0.68) | GRIA2SLC7A5ALPIPKMPTGS1 | |
| SCHEMBL30476553 | 0.88 | SLC7A5 (0.68) | GRIA2SLC7A5ALPIPKMPTGS1 | |
| SCHEMBL2005523 | 0.86 | SLC7A5 (0.57) | GRIA2SLC7A5ALPIPKMPTGS1 | |
| SCHEMBL31369787 | 0.85 | GRIA2 (0.69) | GRIA2SLC7A5ALPIPKMPTGS1 | |
| SCHEMBL539481 | 0.85 | PPARG (0.52) | PPARGPPARAMMESRRPSAT1 | |
| SCHEMBL24424989 | 0.84 | SLC7A5 (0.62) | PPARGPPARASLC7A5ALPIPKM | |
| SCHEMBL13509497 | 0.84 | SLC7A5 (0.62) | PPARGPPARASLC7A5ALPIPKM | |
| SCHEMBL93495 | 0.84 | SLC7A5 (0.78) | PPARGPPARAGRIA2SLC7A5ALPI | |
| SCHEMBL180272 | 0.84 | SLC7A5 (0.78) | PPARGPPARAGRIA2SLC7A5ALPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250361274-A1 | PEPTIDE AND PEPTIDE-CONTAINING AGENT | PEPTIDREAM INC. (JP) | 2025-11-27 | — | — | US | disclosed |
| EP-4541805-A1 | PEPTIDE AND PEPTIDE-CONTAINING AGENT | PeptiDream Inc. (JP) | 2025-04-23 | — | — | EP | disclosed |
| WO-2023243120-A1 | PEPTIDE AND PEPTIDE-CONTAINING AGENT | ペプチドリーム株式会社 | 2023-12-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250361274-A1 | PEPTIDE AND PEPTIDE-CONTAINING AGENT | BMP4, BMP1, BMPR2 | PPARG 2415/4885PPARA 2375/4885GRIA2 3715/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.